Friday, Oct 09th

Last update03:12:59 AM GMT

You are here News Health FDA advisers weigh risks of asthma drugs

FDA advisers weigh risks of asthma drugs

E-mail Print PDF

Experts from the Food and Drug Administration's safety office are recommending that medications like Advair and Symbicort no longer be used to treat children with asthma because of the risk of serious breathing problems. But the FDA office that oversees respiratory drugs says most patients benefit from the medications, and the risks can be addressed through warnings and educational materials for patients and doctors.

TVNL Editor's Personal Comment: Advair almost killed me. It made my asthma life threatening. It made so bad that rescue inhalers did not work.  I have been weened off of it since June 30th of 2008 and I have had chronic asthma, but rescue inhalers work and the severity of my ashma has reduced by approximately 70%.


Most Recent Related Stories...

Obama signs bill preventing healthcare cost increase

ObamaPresident Obama signed changes into Obamacare preventing health insurance premium increases for millions.The rare bipartisan changes,...

California governor signs assisted suicide bill

California assisted suicide bill signedCalifornia will become the fifth state to allow terminally ill patients to legally end their lives...

FDA approves new treatment for advanced lung cancer

new lung cancer drugThe Food and Drug Administration approved a new drug for patients with advanced non-small cell lung...

Scientists share Nobel Prize for medicine for anti-parasite drugs

Nobel in medicineThree scientists from Japan, China and Ireland whose discoveries led to the development of potent new...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!